Search research articles
Contact Us
Filters
Showing results (211-220 of 251) with videos related to
Page
of 26
Sort By:
Journal of Hepatology
|
August 13, 2025
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma
Hyehyun Jeong, Ji-Hye Oh, Hee-Sung Ahn, et al.
British Journal of Cancer
|
May 21, 2020
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
Changhoon Yoo, Sang Soo Lee, Ki Byung Song, et al.
Plos One
|
April 13, 2019
Stereotactic body radiation therapy for locally advanced pancreatic cancer
Jinhong Jung, Sang Min Yoon, Jin-Hong Park, et al.
Cancer Research and Treatment
|
April 28, 2023
ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
Shinkyo Yoon, Miso Kim, Yong Sang Hong, et al.
Journal of Gastrointestinal Cancer
|
May 25, 2021
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index
Giulia Rovesti, Francesco Leone, Giovanni Brandi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2026
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab
Andrea Casadei-Gardini, Terry Cheuk-Fung Yip, Alessandro Vitale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Bevacizumab plus erlotinib in advanced solid cancers with Krebs cycle gene mutations: A multicenter phase II study (BRISK; KCSG AL22-16)
Hyehyun Jeong, Changhoon Yoo, Shinkyo Yoon, et al.
Journal of Gastrointestinal Cancer
|
February 5, 2021
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index
Giulia Rovesti, Francesco Leone, Giovanni Brandi, et al.
Journal of Hepatology
|
November 12, 2024
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
Changhoon Yoo, Hyehyun Jeong, Jae Ho Jeong, et al.
Nature Cancer
|
June 12, 2023
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
Changhwan Sung, Jinhyeon An, Soohyeon Lee, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 251) with videos related to
Sort By:
Page
of 26
Journal of Hepatology
|
August 13, 2025
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma
Hyehyun Jeong, Ji-Hye Oh, Hee-Sung Ahn, et al.
British Journal of Cancer
|
May 21, 2020
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
Changhoon Yoo, Sang Soo Lee, Ki Byung Song, et al.
Plos One
|
April 13, 2019
Stereotactic body radiation therapy for locally advanced pancreatic cancer
Jinhong Jung, Sang Min Yoon, Jin-Hong Park, et al.
Cancer Research and Treatment
|
April 28, 2023
ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
Shinkyo Yoon, Miso Kim, Yong Sang Hong, et al.
Journal of Gastrointestinal Cancer
|
May 25, 2021
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index
Giulia Rovesti, Francesco Leone, Giovanni Brandi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2026
Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab + tremelimumab
Andrea Casadei-Gardini, Terry Cheuk-Fung Yip, Alessandro Vitale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Bevacizumab plus erlotinib in advanced solid cancers with Krebs cycle gene mutations: A multicenter phase II study (BRISK; KCSG AL22-16)
Hyehyun Jeong, Changhoon Yoo, Shinkyo Yoon, et al.
Journal of Gastrointestinal Cancer
|
February 5, 2021
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index
Giulia Rovesti, Francesco Leone, Giovanni Brandi, et al.
Journal of Hepatology
|
November 12, 2024
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
Changhoon Yoo, Hyehyun Jeong, Jae Ho Jeong, et al.
Nature Cancer
|
June 12, 2023
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
Changhwan Sung, Jinhyeon An, Soohyeon Lee, et al.
Page
of 26